2009
DOI: 10.1002/jmv.21600
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of the diversity of the HIV‐1 pol gene and drug resistance associated changes among drug‐naïve patients in Burkina Faso

Abstract: A cross-sectional study was undertaken among drug-naïve HIV patients at the University Hospital in Ouagadougou shortly before and after the introduction of large-scale antiretroviral therapy (ART) in Burkina Faso. Baseline clinical and virological data as well as protease (PR) and 5' reverse transcriptase (RT) sequences from 104 HIV infected patients were analyzed. Genotypic classification revealed the following subtypes and recombinant forms: CRF06_cpx, n = 46 (44.2%); CRF02_AG, n = 39 (37.5%); subtype A, n =… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

10
15
0

Year Published

2013
2013
2016
2016

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(25 citation statements)
references
References 42 publications
10
15
0
Order By: Relevance
“…Subtype G is the second most prevalent HIV-1 clade in West Africa accounting for nearly 30% of infections in the region [4]. Its prevalence greatly varies within and between countries, comprising 30–50% of HIV-1 infections across different regions from Nigeria [5], [6], [7], [8], [9], [10], [11], [12], 5–15% in Benin, Niger and Togo [13], [14], [15], [16], [17], and ≤4% in other western African countries [14], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30]. Similarly, the occurrence of the CRF06_cpx clade ranges from 40–50% of HIV-1 infections in Burkina Faso [18], [19], [20], to 5–15% in Benin, Ghana, Mali, Niger, Nigeria, Senegal and Togo [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [21], [22], [23], [24], [28], [29], and <3% in other western African countries [14], [26], [27], [30].…”
Section: Introductionmentioning
confidence: 99%
“…Subtype G is the second most prevalent HIV-1 clade in West Africa accounting for nearly 30% of infections in the region [4]. Its prevalence greatly varies within and between countries, comprising 30–50% of HIV-1 infections across different regions from Nigeria [5], [6], [7], [8], [9], [10], [11], [12], 5–15% in Benin, Niger and Togo [13], [14], [15], [16], [17], and ≤4% in other western African countries [14], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30]. Similarly, the occurrence of the CRF06_cpx clade ranges from 40–50% of HIV-1 infections in Burkina Faso [18], [19], [20], to 5–15% in Benin, Ghana, Mali, Niger, Nigeria, Senegal and Togo [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [21], [22], [23], [24], [28], [29], and <3% in other western African countries [14], [26], [27], [30].…”
Section: Introductionmentioning
confidence: 99%
“…Both HIV-1 and HIV-2 are present in the region and two HIV-1 circulating recombinant forms (CRFs) dominate the epidemic in Burkina Faso: CRF02_AG and CRF06_cpx (Tebit et al, 2006;Tebit et al, 2009). CRFs represent recombinant HIV-1 genomes that have infected three or more persons who are not epidemiologically related, so they can be assumed to have an epidemiologically relevant contribution to the HIV-1 M group epidemic (LANL, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Although these samples came from one hospital in Quagadougou, almost thirty years later the same CRFs are still predominant and co-circulating today and causing infections in Burkina Faso, with no significant change in proportion between CRF06_cpx and CRF02_AG [62], [63]; thus, strongly suggesting the same strains that initiated the early epidemic. Similarly, Kalish et al [24] found the distribution of HIV-1 strains in Kinshasa, Zaire from 1984 through 1986 were composed of CRF01_AE, unique recombinant viruses, unclassifiable strains, and all the group M subtypes but B.…”
Section: Discussionmentioning
confidence: 99%